Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-24 00:00:00 ET · period of report 2021-08-20 · accession 0001237899-21-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-24 | 2021-08-20 | REGN | LAROSA JOSEPH J | EVP GC, Secret | F - Tax | $664.85 | -6,575 | 16.6K | -28% | -$4.37M |
| DM | 2021-08-24 | 2021-08-23 | REGN | LAROSA JOSEPH J | EVP GC, Secret | S - Sale+OE | $661.84 | -3,425 | 13.2K | -21% | -$2.27M |
| D | 2021-08-24 | 2021-08-20 | REGN | LAROSA JOSEPH J | EVP GC, Secret | M - OptEx | $179.13 | +10.0K | 23.2K | +76% | +$1.79M |
| D | 2021-08-24 | 2021-08-20 | REGN | LAROSA JOSEPH J | EVP GC, Secret | M - OptEx | $0.00 | -10.0K | 30.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-20 | F | D | 6,575 | $664.85 | 16,607 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-23 | S | D | 3,383 | $661.80 | 13,224 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-23 | S | D | 41 | $665.40 | 13,183 | D | — | — | (F2) Represents volume-weighted average price of sales of 41 shares of Company stock on August 23, 2021 at prices ranging from $665.21 to $665.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price. |
| 4 | Common | Common Stock | 2021-08-23 | S | D | 1 | $666.22 | 13,182 | D | — | — | |
| 5 | Common | Common Stock | 2021-08-20 | M | A | 10,000 | $179.13 | 23,182 | D | — | — | |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-20 | M | D | 10,000 | $0.00 | 30,000 | D | $179.13 · — to 2022-12-14 | 10,000 Common Stock | (F3) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |